Short-Term Progression of Multiterritorial Subclinical Atherosclerosis
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized Study
Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Negative Risk Markers for Cardiovascular Events in the Elderly
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes